Genmab — Juni 2025

[E_L]

The EPCORE NHL-2 trial: epcoritamab plus GemOx in transplant-ineligible R/R DLBCL https://www.youtube.com/watch?v=w1GmTshxnbU

[E_L]

ICML 2025 | Results from EPCORE NHL-2 trial of epcoritamab + R-CHOP for previously untreated DLBCL https://www.youtube.com/watch?v=9sco80a47i4

[E_L]

DARZALEX (daratumumab) receives the first positive CHMP opinion for patients with high-risk smouldering multiple myeloma https://www.globenewswire.com/news-release/2025/06/20/3102621/0/en/DARZALEX-daratumumab-receives-the-first-positive-CHMP-opinion-for-patients-with-high-risk-smouldering-multiple-myeloma.html

[E_L]

Lymphoma Hub
@lymphomahub 18ICML Fixed-duration epcoritamab monotherapy led to high response rates (ORR, 78%; CR rate, 70%) and a manageable safety profile in older, anthracycline-ineligible patients with LBCL. These results suggest that epcoritamab monotherapy is a promising chemotherapy-free treatment option for this patient population. https://x.com/lymphomahub/status/1935994273180025220

[lahn1]

Tak EL og god weekend til alle.

[Helge_LarsenPI-redaktør]

Godmorgen

[Budweis]

Novo Nordisk med lovende nyt om mim8 https://www.novonordisk.com/content/nncorp/global/en/news-and-media/news-and-ir-materials/news-details.html?id=916355

[ProinvestorNEWS]

Roche closes in on Epkinly with SC Lunsumio data in lymphoma https://firstwordpharma.com/story/5975116

[E_L]

small new trial - A Study of Epcoritamab With Lenalidomide and Tafasitamab in People With Diffuse Large B Cell Lymphoma (ECLAT) https://clinicaltrials.gov/study/NCT07030699

[Raun]

Meget høj omsætning i US til aften... - Især den sidste time har der været meget stor omsætning?

[E_L]

Shirley Chen
Barclays
Buy Kr.1,875.00 Maintained Today 24-6-25 -that's a new analyst, same target as previous

[lahn1]

Så er der spændende nyt i sagen mod Abbvies. Se indlæg i debatten. Defendants respectively request that AbbVie's Complaint be dismissed. https://proinvestor.com/boards/126977/

[ProinvestorNEWS]

Genmab-kræftmiddel på vej mod blockbusterstatus https://proinvestor.com/investornyt/1332433/genmab-kraeftmiddel-pa-vej-mod-blockbusterstatus (artiklen kræver ikke abonnement)

[E_L]

FRONTIER5 direct switch study: Safety of initiating Mim8 prophylaxis without washout of Emicizumab https://sciencehub.novonordisk.com/congresses/isth2025/johannes-oldenburg.html

[E_L]

ISTH 2025
21 - 25 June 2025
Mim8 enhances procoagulant activity of select hemophilia B-causing factor IX variants https://sciencehub.novonordisk.com/congresses/isth2025/sebastian-leyes-porello.html

[Sukkeralf]

Tak lahn1

[Raun]

OMG om jeg forstår denne aktie..... Så har igen set en 10% reduktion uden noget negativt - tværtimod?

[E_L]

my guess is that is has something to do with Klimovsky filing a form 144 with the SEC last week (which means she plans to sell some shares , 1300 in the next 90 days). (IF that is it, it is ofcourse completely over-exaggerated...)

[E_L]

i actually thought she spoke really well at the recent Jefferies
Health Care Conference

[Raun]

Er det ikke også bemærkelsesværdig at omsætningen var 2,5x normalen i går i US? og så ser vi denne lunkne performance dagen efter i DK - vel at mærke i et positivt marked?